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A B S T R A C T
Objectives: To evaluate the ability of a modiﬁed in situmodel to diﬀerentiate dentinal tubule occlusion properties
of toothpaste formulations over 10 days of treatment.
Methods: This was a single-centre, three-treatment period, crossover, randomised, single-blind study with
healthy participants wearing two lower oral appliances, each retaining four dentine samples, for 10 treatment
days during each period of the study. Samples were power-brushed ex vivo twice on each treatment day with a
Test toothpaste containing 0.454% stannous ﬂuoride, a Control ﬂuoride toothpaste containing 0.76% sodium
monoﬂuorophosphate, or mineral water. Dentine samples were subjected to in situ acid challenge (orange juice)
on Days 9 and 10. Scanning electron microscopy images obtained at baseline and after 1, 4, 8 and 10 days of
treatment were graded for degree of surface coverage by four calibrated examiners; the primary study endpoint
was Day 8.
Results: After 4, but not 8, days’ treatment, the degree of tubule occlusion increased in the dentine samples
treated with the Test or Control toothpastes compared with the water-treated samples (p < 0.01 and p < 0.05,
respectively). Following the acid challenge (Day 10), there was a statistically signiﬁcantly greater degree of
occlusion in the Test toothpaste-treated dentine samples compared with those treated with water (p < 0.01). No
other comparisons were statistically signiﬁcant. All study treatments were generally well-tolerated.
Conclusions: This modiﬁed in situ model was unable to demonstrate statistically signiﬁcant between-treatment
diﬀerences in dentinal tubule occlusion after 8 days. Conversely, there are recognised developments that could
be made to better identify product diﬀerences. Clinicaltrials.gov: NCT02768194.
Clinical signiﬁcance: Dentine hypersensitivity can be managed through brushing with stannous ﬂuoride tooth-
pastes, which occlude patent dentine tubules. Clinical studies measure pain but in situ models are needed to
demonstrate occlusion intra-orally. However, this study did not demonstrate superior occlusion with stannous
toothpaste; further methodological development is required to investigate its mode of action.
1. Introduction
Dentine hypersensitivity (DH) results primarily from exposure of
patent dentinal tubules due to gingival recession and/or enamel loss
(e.g., through erosion or abrasion) [1–3]. The characteristic short, sharp
pain of DH is thought to result from an external stimulus, such as a
temperature or osmotic diﬀerential, causing ﬂuid movement within
exposed dentinal tubules, which in turn stimulates nerve processes in
the pulpal area of the dentine [4,5].
Based on its presumed aetiology, management of DH with home-use
oral-care products may be approached either by depolarisation of the
aﬀerent nerve membrane to block the pain response or by physically
occluding the dentinal tubules, thus reducing dentinal ﬂuid movement
and pulpal nerve irritation [6,7]. Tubule-occluding agents, such as
strontium and stannous salts, bioglasses, silicas or oxalates [8–13], seal
or block the dentinal tubules by precipitating insoluble materials onto
the dentine surface and/or within the dentinal tubules, thereby redu-
cing the eﬀect of external stimuli on dentinal ﬂuid movement [14].
Some evidence suggests that occlusion-based agents may provide faster
relief of DH than those based on nerve depolarisation [15].
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Stannous ﬂuoride (SnF2) has been incorporated into oral hygiene
products since the 1960s [16] and there is substantial published clinical
evidence that SnF2-containing toothpastes can reduce DH [8,11,17].
SnF2 is believed to provide relief from DH by occluding dentinal tubules
through chemical precipitation of tin oxides and hydroxides onto the
dentine surface, with other salivary constituents and particulates from
the formulation [18,19]. This precipitate has been shown in vitro to be
relatively resistant to solubilisation by dietary acids [20]. Stannous ions
in neutral aqueous solution tend to oxidise to the stannic state and form
hydroxide precipitates. This can be avoided by formulating the ion in
non-aqueous, glycerin-based toothpaste formulations that have similar
viscosity/ﬂow characteristics to conventional aqueous products. Such
products release the stannous ion on dilution in saliva during use [11].
Based on in vitro data, a formulation of a marketed anhydrous SnF2
toothpaste with a modiﬁed polymer system based on polyacrylate
(carbomer) in a glycerin-polyethylene glycol non-aqueous liquid phase
has recently been developed; this allows more rapid and complete de-
position of occluding precipitates [21].
The ability of this new formulation to relieve DH is being assessed in
a comprehensive programme of clinical trials [22–24]. An in situ model
has been developed for clinical evaluation of tubule occlusion proper-
ties of toothpastes [25] using a conventional scanning electron micro-
scope (SEM) and applying a replica technique to identify diﬀerences
between positive and negative control DH toothpastes. SEM images of
the impression of the dentine surface were independently scored by up
to four individuals using a visual grading system. This model has now
been further developed to use direct SEM imaging to successfully and
reproducibly assess the occlusive eﬀects of toothpastes for the relief of
DH in vitro [17] and in situ [26–29].
In the present study, the tubule occlusion properties of an experi-
mental toothpaste formulation containing 0.454% w/w SnF2 were
compared with those of a conventional ﬂuoride toothpaste and a ne-
gative control (mineral water) over a 10-day period using a modiﬁca-
tion of the previously reported in situ model [26–30]. In addition, the
robustness of any occlusion generated by the treatments was tested by
exposing the dentine samples to an acid challenge (orange juice) after 9
and 10 days’ treatment. The extent of tubule occlusion (surface cov-
erage) was examined by direct SEM [27,28,30]. Modiﬁcations to the
previously used in situ model included (i) the timeframe of the model,
which was extended from the usual 4 days to 10 days of treatment; and
(ii) the baseline score for each specimen was paired with its post-
treatment score, thus each specimen provided its own control. The null
hypothesis was that there is no diﬀerence in the occluding potential of a
test and control toothpaste after 8 days of treatment.
2. Methods
This was a single-centre, single-blind (with respect to the dentine-
sample analyst responsible for SEM and image grading), randomised,
three-treatment, three-period, crossover, in situ study in healthy parti-
cipants. The study was conducted in accordance with the Declaration of
Helsinki at a UK Dental School, with ethical approval given by National
Research Ethics Service (NRES) Committee South West – Exeter in-
dependent ethics committee (Research Ethics Committee [REC] Ref:
16/SW/0123). The study is registered at clinicaltrials.org; study
number NCT02768194.
2.1. Participants
Participants were recruited by the study site. The eligible study
population comprised healthy adults aged 18–80 years with good
general and oral health and the ability to accommodate two lower bi-
lateral buccal oral appliances, each ﬁtted with four dentine samples.
Exclusion criteria included pregnancy; breastfeeding; current or re-
current disease or dental pathology that could have aﬀected study
outcomes; current susceptibility to acid regurgitation; orthodontic
appliances, restoration, bridgework or dentures that could have inter-
fered with study assessments; recurrent or regular aphthous ulcers;
severe gingivitis, carious lesions or periodontal disease; signs of severe
dental erosion; any condition or medication that was causing xer-
ostomia; and requirement for antibiotic prophylaxis for dental proce-
dures.
2.2. Dentine samples and buccal appliances
During the study, participants wore lower left and lower right
buccal appliances, each ﬁtted with four dentine samples (eight samples
in total), as described previously [25]. Dentine samples were obtained
from recently extracted caries-free human third molars, donated to a
Tooth Tissue Bank under ethical approval by NRES Committee
Northern Ireland (REC Ref: 11/NI/0145). The roots were sectioned
using a microslice (Ultra Tec Manufacturing Inc, Santa Ana, CA, USA)
to obtain the dentine samples, which were then embedded in dental
composite (QUIXFIL; Dentsply, Weybridge, UK). Each dentine sample
was polished using a lapping and polishing machine (Kent 3 Automatic;
Kemet International Ltd, Maidstone, UK) to produce a ﬂat, level sample
with parallel sides. The dentine samples were then etched with 10%
citric acid for 30 s and washed in copious amounts of distilled water to
expose the dentine tubules. Samples were stored in 0.9% saline solution
until use.
Before use, each dentine sample was analysed using a non-de-
structive Phenom G2 pro desktop SEM (PhenomWorld, Eindhoven, The
Netherlands) and the image was recorded. Each sample image was as-
sessed by the sample-preparation technician for degree of tubule pa-
tency by visual grading using a categorical grading system (occlusion
classiﬁcation scale: 0 = not evaluable; 1 = occluded; 2 = mostly oc-
cluded; 3 = equally occluded/unoccluded; 4 = mostly unoccluded; 5
= unoccluded) [19]. Only dentine samples demonstrating minimal
occlusion (≥4) were included in the study. SEM micrographs of the
dentine samples deemed appropriate for use in the study formed the
basis of the baseline occlusion classiﬁcation score for each sample.
Following baseline SEM analysis, the samples were stored in 0.9%
saline solution at 5 °C until placement in the buccal appliance. The
dentine samples and appliance were disinfected before insertion in the
mouth. When the dentine samples were removed from the appliances
for SEM analysis at the end of Days 1, 4 and 8 (one from each appli-
ance), a blank acrylic replicate of the dentine sample was inserted into
the appliance to maintain a constant feel to the participant. Four new
dentine samples were placed in the appliances for each treatment
period.
2.3. Study products
Three study products were tested in separate treatment periods: Test
toothpaste containing anhydrous 0.454% w/w SnF2; Control ﬂuoride
toothpaste containing 0.76% w/w sodium monoﬂuorophosphate (US
Colgate® Cavity Protection; Colgate-Palmolive Company, New York,
NY, USA); Volvic® mineral water (Danone, Paris, France). The study
toothpastes were supplied in tubes over-wrapped in opaque vinyl with
any branding obscured to maintain the study blind as far as possible.
The mineral water (for negative control, rinsing and moist storage pots)
was supplied in commercial bottles.
2.4. Study visits
The study comprised a screening visit followed by three treatment
periods, each consisting of 10 non-consecutive treatment days (to be
completed within 25 days of the ﬁrst treatment day), with a wash-out
period of at least 24 h (maximum 15 days) between treatment periods.
At the screening visit, participants provided written informed consent
and a medical history was taken. Participants underwent full oral soft
tissue (OST) and hard tissue examinations and were screened for
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eligibility. Eligible participants were provided with a standard ﬂuoride
toothpaste (US Colgate® Cavity Protection; Colgate-Palmolive
Company, New York, NY, USA) and manual toothbrush (Aquafresh®
Clean Control; GSK Consumer Healthcare, Weybridge, UK) and were
instructed to brush twice-daily at home in their usual manner for the
duration of the study. Participants were not permitted to use any other
oral-care products, except for dental ﬂoss.
At the start of the ﬁrst treatment period (between 1 and 15 days
after the screening visit), eligible participants were randomised to the
sequence in which their dentine samples received the three study
treatments (one study product per treatment period). Randomisation
numbers were assigned in ascending numerical order as each partici-
pant was determined to be fully eligible. The randomisation schedule
used a balanced pair of Williams squares generated by the Biostatistics
Department of GSK Consumer Healthcare.
The procedure ﬂow on treatment days is summarised in Fig. 1. On
treatment days, participants brushed with the standard ﬂuoride tooth-
paste before attending the study site and brushed with it again in the
evening after all study assessments had been completed. During the
treatment day, each participant wore the oral appliances from 09:00
h ± 30min to 15:30 h ± 30min. On the morning of the treatment
day, participants wore their appliances for at least an hour before the
appliances were removed for ex vivo application of the study treatment.
Applications of study treatments were scheduled at 10:00
h ± 30min and 14:30 h ± 30min. Depending on the randomisation
schedule, dentine samples retained within the appliances were im-
mersed in either a slurry of freshly prepared treatment toothpaste (1:3
w/w in mineral water) or in mineral water alone. They were brushed ex
situ by the study staﬀ using an electric toothbrush (Oral B® Vitality
Precision Clean power toothbrush with EB17 Precision Clean brush
head; Procter & Gamble, Weybridge, UK) for 1 timed minute (2min
total for both of the participant’s appliances; 15 s for each sample, in-
cluding the acrylic substitutions).
The appliances were returned to the participant’s mouth and the
participant rinsed with 10mL of mineral water for approximately 5 s
and expectorated. The appliances were worn for at least 1 h before
lunch. The appliances were removed from the mouth and stored in a
moist pot for up to 1 h while the participants had lunch. This treatment
schedule was repeated in the afternoon, ensuring ﬁrst that the appli-
ances were worn for at least 1 h following lunch, prior to treatment and
Fig. 1. Flow of procedures during treatment days.
aProcedure only conducted on Treatment Days 9 and 10.
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for at least 1 h following the second treatment of the day. As such,
participants wore the appliances for at least 4 h on each treatment day.
At the end of each treatment day, appliances were stored in a moist pot
at the study site.
At the end of treatment days 1, 4, 8 and 10, one dentine sample was
removed from each appliance (two samples in total per participant) for
SEM analysis. On Days 9 and 10 of each treatment period, acid chal-
lenges were conducted at 11:30 h ± 30min and 15:30 h ± 30min (a
minimum of 60min after the morning and afternoon treatments, re-
spectively). With both of the appliances in situ, the participants swished
a total of 250mL of orange juice around their mouth under supervision
over a 10-minute period (25mL/min), expectorating after approxi-
mately 1min. Participants then rinsed their mouth for 5 s with 10mL of
mineral water. Following the afternoon acid challenge and mineral-
water rinse (15:30 h ± 30min), appliances were removed from the
mouth and stored in moist pots at the study site.
2.5. Assessments
The extent of tubule occlusion was assessed by appropriately trained
examiners grading SEM images at baseline, following days 1, 4, 8 and
10. The SEM used was capable of imaging without sputter-coating the
samples with conductive material (standard for SEM methodologies to
avoid charge build-up on the sample resulting in defocused images),
thus enabling samples to be directly imaged to identify patent tubules
prior to them being placed in the oral cavity. Images captured before
intra-oral use were scored and paired with their post-treatment sample
scores.
The approximate same area on the specimen surface was imaged at
baseline and after treatment. Images were captured at ×2000 magni-
ﬁcation. The pre- and post-treatment SEM images were independently
scored according to the occlusion classiﬁcation scale (as above) [17] by
four trained, validated, blinded examiners and the scores for each
specimen were paired. All examiners scored all images, which were
presented to them in random order.
A calibration exercise was performed for dentinal tubule occlusion
classiﬁcation scoring of SEM images before study commencement. Four
examiners graded the same 25 standard images obtained from a pre-
vious study. Assessments were compared with the calibration standard
assessments. Each of the examiner’s scores was cross-tabulated against
the calibration standard. A weighted kappa coeﬃcient (κ) was calcu-
lated using the Fleiss–Cohen method of weighting [31] to assess inter-
examiner reliability and presented along with 95% conﬁdence intervals
(CIs). Reliability was deemed to be ‘excellent’ if κ > 0.75; ‘fair to good’
if κ≥ 0.4 and ≤0.75; and ‘poor’ if κ < 0.4. ‘Excellent’ reliability was
required for an examiner to be selected.
2.6. Safety
Oral examinations were performed at screening, at the end of each
treatment period and at a follow-up visit within 7 days of the ﬁnal
treatment visit or participant withdrawal. Adverse events (AEs) and any
appliance incidents were recorded from the ﬁrst use of standard
ﬂuoride toothpaste until 7 days after the end of the third treatment
period. Safety was assessed from OST examination ﬁndings and AEs
reported by participants following re-insertion of oral appliances in the
mouth after treatment. All analyses of safety were made on the safety
population, deﬁned as all participants who were randomised and had
the oral appliances re-inserted in the mouth after ex vivo treatment
application. The safety population was analysed as per treatment re-
ceived.
2.7. Statistical analysis
At least 24 eligible participants were planned to be randomised to
ensure approximately 20 completed the entire study. With 20
participants, using a paired t test, a treatment diﬀerence of 0.69 units
could be detected with 80% power, assuming 1.1 as the variance of
paired diﬀerences. The estimate for variance was obtained from an
earlier study [29] where all residual variances were< 0.55. The intent-
to-treat (ITT) population was deﬁned as all randomised participants
with at least one graded post-treatment SEM image. The primary po-
pulation for analysis was the per-protocol (PP) population, deﬁned as
those in the ITT population for whom all post-baseline SEM image
scores were deemed to be unaﬀected by protocol violations. For one
participant, the Period 1, Day 10 SEM data were deemed to be aﬀected
by a protocol violation (samples being outside the mouth for a longer
duration than speciﬁed), resulting in exclusion of data for this time-
point only.
The primary eﬃcacy variable was change from baseline in mean
occlusion classiﬁcation score. This was calculated separately for each
sample as the mean of the values from the independent classiﬁcations of
the four examiners. The mean was calculated only if at least two of the
four examiners assigned a score> 0. The primary objective was to
evaluate the model’s ability to diﬀerentiate the dentinal tubule occlu-
sion properties between the Test toothpaste and water (negative con-
trol) after 8 days of treatment. The secondary objective was to evaluate
the model’s ability to diﬀerentiate the dentinal tubule occlusion prop-
erties of the toothpaste formulations after 1, 4 and 10 days’ treatment.
The change from baseline in the mean occlusion classiﬁcation score
was analysed using a mixed-model repeated-measures (MMRM) ana-
lysis with participant included as a random factor, and treatment,
period, day, side of the mouth and treatment× day interaction in-
cluded as ﬁxed factors; baseline mean SEM score was the covariate.
Participant (period) was the unit for the repeated measure analysis and
the speciﬁed covariance matrix was the Kronecker product of a 4×4
unstructured matrix and a 2× 2 matrix with compound symmetry
corresponding to the 4 days in each period and the two sides of the
mouth for each day. This model was used to compare treatments at the
5% level at 8 days using appropriate contrasts for the factors of treat-
ment and treatment× day; p-values and 95% CIs were tabulated for the
diﬀerences. The same MMRM model was used to compare treatments at
1, 4 and 10 days using corresponding appropriate contrasts for the
factors of treatment and treatment× day. The assumption of normality
and homogeneity of covariance for residuals was investigated and
found to be acceptable. Note that no adjustment for multiple compar-
isons was made as a primary eﬃcacy assessment had been pre-speci-
ﬁed.
3. Results
A total of 26 participants were screened, 24 were randomised to
study treatments and 21 completed all three treatment periods (Fig. 2).
The ﬁrst participant was enrolled on 6 July 2016; the last participant
completed the study on 21 September 2016. All randomised partici-
pants were included in the safety population (n= 24), the mean age of
whom was 41.4 years (range 20–61 years; standard deviation 13.31
years). The majority of participants were female (13/24 [54.2%]). No
participants were excluded from the PP population due to protocol
violations. Kappa scores for the four examiners were very similar (Ex-
aminer 1: 0.93 [95% CI 0.89, 0.99]; Examiner 2: 0.92 [0.85, 0.98];
Examiner 3: 0.90 [0.79, 1.00]; Examiner 4: 0.87 [0.75, 0.99]). Relia-
bility of all four was deemed to be ‘excellent’ and all four subsequently
graded the study SEM images.
3.1. Eﬃcacy
The raw mean occlusion scores of the dentine samples at baseline
and following removal from the appliances after 1, 4, 8 or 10 days are
provided in Table 1 for each treatment. Fig. 3 summarises the change
from baseline in the mean occlusion scores over time by treatment. The
results of the between-treatment analyses are summarised in Table 2.
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While the occlusion scores for the dentine samples treated with ei-
ther the Test or the Control toothpaste reduced (i.e., degree of occlusion
increased) with time, there were no statistically signiﬁcant diﬀerences
in occlusion scores between any of the treatment groups at Day 8 (the
primary eﬃcacy measure). At Day 4, compared with the samples
treated with water, there was a statistically signiﬁcantly greater degree
of occlusion for the dentine samples treated with either the Test or the
Control toothpaste (p= 0.0023 and p= 0.0194, respectively); how-
ever, there was no statistically signiﬁcant diﬀerence between the two
toothpaste groups at this timepoint. Following the acid challenges (Day
10), there was a statistically signiﬁcantly greater degree of occlusion in
the Test toothpaste-treated dentine samples versus those treated with
water (p=0.0058). No other comparisons were statistically signiﬁcant.
3.2. Safety
Eleven treatment-emergent AEs were reported by six participants; of
these, two were oral (tooth sensitivity and tooth fracture) and nine were
non-oral. All treatment-emergent AEs were mild in intensity except for
the tooth fracture, which was of moderate intensity. All AEs resolved by
the end of the study. One participant was withdrawn from the study due
to the tooth-sensitivity AE, which was ascribed to exposure to the acid
challenge (orange juice) used in the study. No treatment-related AEs, no
Fig. 2. Flow chart of participant disposition.
Footnote: ‘Other’ reasons for non-completion of the treatment period included reasons other than not meeting the study criteria, experiencing adverse events, being
lost to follow-up, protocol deviation or withdrawal by the participant. ITT, intent-to-treat; PP, per-protocol.
Table 1
Mean tubule occlusion score in dentine samples before and after treatment (per-
protocol population).
Test toothpaste
(N=23)
Control toothpaste
(N=22)
Water (N=24)
Timepoint Before
(n= 46)
After
(n=46)
Before
(n= 44)
After
(n= 44)
Before
(n=48)
After
(n= 48)
Day 1 4.30
(0.062)
3.96
(0.085)
4.38
(0.055)
4.13
(0.116)
4.30
(0.070)
3.86
(0.139)
Day 4 4.41
(0.069)a
3.51
(0.123)a
4.30
(0.070)
3.60
(0.127)
4.23
(0.058)
3.98
(0.110)
Day 8 4.38
(0.056)
3.43
(0.112)
4.32
(0.078)
3.42
(0.114)
4.36
(0.060)b
3.53
(0.130)b
Day 10 4.31
(0.062)b
3.13
(0.144)b,c
4.31
(0.063)
3.49
(0.127)c
4.36
(0.066)d
3.74
(0.133)c,d
Data are raw means (standard error). N, number of participants; n, number of
dentine samples.
a n=45 (one sample missing).
b n= 44.
c After 2 days of acid challenges.
d n= 42.
Fig. 3. Mean change in tubule occlusion score from baseline (per-protocol
population).
Data shown are adjusted means ± standard errors. aFollowing 2 days of acid
challenges. [Greyscale ﬁgure can be used for print]
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serious AEs, and no medical device incidents were reported.
4. Discussion
Stannous ions have previously been found eﬀective in reducing the
pain of DH in clinical studies when formulated into toothpastes in the
form of SnF2 [28,32–34] and stannous chloride combined with sodium
ﬂuoride [35]. The exploratory SnF2 toothpaste used in this study has
been shown in clinical trials to reduce the severity of DH pain compared
with conventional ﬂuoride toothpaste in studies ranging from single
brushing to 14 days’ twice-daily brushing [22–24]. Similar formulations
have shown beneﬁts after 4 and 8 weeks of use [28,29].
In vitro studies have shown that SnF2 in toothpaste forms a surface
coating over the dentine and penetrates into the dentine tubules [19].
The development of an in situ model that allows direct and non-de-
structive imaging of the dentine surface before and after treatment has
allowed a greater understanding of how components in toothpastes
interact with the dentine surface in a clinical situation [25,28,29]. Di-
rect imaging of the surface, or even below the surface, of dentine
samples allows visualisation of the physical interaction and the level of
tubular occlusion that leads to the reduction of DH identiﬁed during
clinical studies. The ability to score dentine images before inclusion in
an in situ study should strengthen the outcome of a study as each spe-
cimen acts as its own control.
The modiﬁed in situ model used here has not previously been cor-
related with short-term SnF2 DH studies so the purpose was to explore
whether this model reﬂected the tubule-occluding properties of SnF2
toothpastes observed in clinical studies. A similar model has previously
been able to demonstrate dentinal tubule occlusion by toothpastes
formulated with other occluding agents when run for a total of 4 days (2
days without acid challenges, then 2 days with acid challenges) [25].
The same model has also shown statistically signiﬁcantly greater oc-
clusion for a similar SnF2 formulation to the one in the present study
when compared with the same control toothpaste after 2, 3 and 4 days
[28,29]. Of note, the water and control toothpaste in the latter study
[29] gave occlusion scores that were essentially constant for all treat-
ment days, in contrast to the variable scores seen across treatment days
in this study.
In vitro studies using SEM have demonstrated the ability of stannous
ions to occlude dentine tubules in laboratory conditions. A study of two
SnF2-containing toothpastes – one aqueous, one non-aqueous – showed
they were more eﬀective in occluding dentinal tubules by both visual
analysis of SEM images and hydraulic conductance, than a regular
toothpaste. This diﬀerence was maintained after acid treatment [20].
Another study, which used focused ion-beam SEM to image a cross-
section of the dentine tubules, showed that a SnF2 dispersion in glycerol
and an experimental anhydrous SnF2 toothpaste both created an oc-
clusive layer that extended into the tubules below the dentine surface
[23].
The principal modiﬁcation made to the model for the current study
was to increase the duration of application from 4 days to 8 days, with a
further 2 days with an acid challenge. This was to evaluate whether a
longer duration of application would facilitate development of a visible
(to the SEM) occluding layer, leading to larger treatment diﬀerences as
previously seen when the model was extended to investigate the oc-
clusion properties of a toothpaste containing calcium sodium phos-
phosilicate (CSPS; Novamin®) [30].
Here, there was no signiﬁcant diﬀerence between groups after 1 day
of application, but a signiﬁcant diﬀerence between the toothpaste
treatment groups and the water treatment group was observed after 4
days of application. This diﬀerence was not observed after 8 days of
treatment application, when the water treatment group showed a
higher degree of occlusion compared with the Day 4 measurement. A
signiﬁcant diﬀerence was shown between the Test toothpaste and water
again at Day 10 following the acid challenges. The treatment eﬀects
observed with the Control toothpaste and water control in this study
were much greater than those seen previously [26,27]. This observation
appears to demonstrate an inherent variability in this clinical metho-
dology, mirrored by the greater than expected variance in the mean
scores, and probably reduced observed treatment diﬀerences. The in-
creased level of occlusion for the Control and water groups in this study
may be as a result of the increased time the appliances resided in the
mouth, allowing more debris, such as salivary constituents and bac-
terial plaque, to build up on the dentine surface. Given this possibility, a
recommendation for future studies would be to incorporate acid chal-
lenges during every day of treatment application.
Care must be taken when comparing results from in situ clinical and
laboratory studies of occlusion as they use diﬀerent measuring instru-
ments; some may determine tubular occlusion by looking directly at the
surface, while other instruments may focus on the sub-surface area.
Similarly, extrapolating results observed in a clinical study to those
observed in an in vitro or in situ study may also be misleading.
A potential drawback of the approach used in this study to quantify
and visualise tubule occlusion is that the surface coverage observable
by SEM, and occlusion of dentine tubules that prevents ﬂuid ﬂow, are
not the same phenomenon. Evidence from in vitro studies suggests that
the deposition critical to tubule occlusion with SnF2, and thus re-
sponsible for DH relief, may be within the dentine tubules rather than at
the dentine surface [23] and so not visible by SEM. The results from this
study strengthen this theory, because viewing the dentine surface from
above did not show any signiﬁcant diﬀerence in the degree of occlusion
from the SnF2 containing toothpaste after 8 days of treatment. Clinical
studies using the same toothpaste have shown it to provide relief from
DH [22–24]. The model may therefore need to be further modiﬁed to
include cross-sectional imaging of the tubules to identify occluding
particles further down inside them. It must also be stated that a further
limitation of this model is that an in situmodel does not allow ﬂuid ﬂow
through the tubules in the same way that is found clinically. The ﬂuid
ﬂow within tubules may be essential to form precipitates following
treatment with SnF2, more so than other agents that have been shown
to occlude the surface when viewed under SEM using this type of oc-
clusion model. Studies on another occlusion technology – CSPS over 10
and 20 days – have suggested that the precipitated layer overlying the
tubules is more substantial and may play a larger role in prevention of
ﬂuid ﬂow in the tubules versus intra-tubular precipitation [30,19].
Treatment diﬀerences were observed to be greatest in numerical terms
at Day 10, consistent with clinical data indicating that degree of DH
Table 2
Between-treatment comparisonsa of mean occlusion scores (per-protocol po-
pulation).
Test toothpaste vs water Test toothpaste vs
Control toothpaste
Control toothpaste vs
water
Day Diﬀerenceb
(95% CI)
p-value Diﬀerenceb
(95% CI)
p-value Diﬀerenceb
(95% CI)
p-value
1 0.10 (-0.23,
0.42)
0.5573 −0.14 (-0.47,
0.19)
0.4044 0.23 (-0.09,
0.56)
0.1569
4 −0.54
(-0.87, -0.20)
0.0023 −0.13 (-0.47,
0.22)
0.4683 −0.41
(-0.75, -0.07)
0.0194
8 −0.11
(-0.46, 0.25)
0.5512 −0.01 (-0.36,
0.35)
0.9671 −0.10
(-0.46, 0.26)
0.5830
10c −0.56
(-0.96, -0.17)
0.0058 −0.33 (-0.72,
0.06)
0.1007 −0.24
(-0.64, 0.16)
0.2430
Values in bold indicate statistically signiﬁcant diﬀerence at p < 0.05.
CI, conﬁdence interval.
a From mixed-model repeated-measures analysis with treatment, period,
day, side of mouth, treatment× day interaction as ﬁxed factors, participant as a
random eﬀect and baseline scanning electron microscope image score as a
covariate. Participant within period was the unit for the repeated measure.
b First-named treatment minus the second-named treatment, such that a
negative diﬀerence favours the ﬁrstnamed treatment.
c After 2 days of acid challenges.
N.X. West et al. Journal of Dentistry 76 (2018) 125–131
130
relief increases with duration of use over this time period [22,23].
5. Conclusions
This modiﬁed in situ model was unable to demonstrate statistically
signiﬁcant diﬀerences in dentinal tubule occlusion by SEM of a SnF2
toothpaste compared with a conventional control toothpaste after 8
days’ use, therefore the null hypotheses cannot be rejected. Further
developments have been identiﬁed for this in situ model that can be
made to improve diﬀerentiation between products. Study treatments
were generally well-tolerated.
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